Search Results
Dec 11, 2025, 18:31 ET New Lancet Phase III Study Shows Proton Therapy Significantly Improves Survival and Reduces Toxicity in Head and Neck Cancers - Marking a Breakthrough in Advanced Cancer Care
toxicities, and it joins a short list of trials which have shown an improvement in overall survival with a change in radiotherapy technique," added Mark W. McDonald, MD, Medical Director at Emory Proton Therapy Center, an NAPT Board Member and an NAPT Physician Advisory Committee member.In addition
More news about: The National Association for Proton Therapy
Dec 11, 2025, 18:09 ET FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
cell depletion identified in muscle-specific kinase myasthenia gravis. JCI Insight. 2017;2(17):e94263.Ye Y, Murdock DJ, Chen C, Liedtke W, Knox CA. Epidemiology of myasthenia gravis in the United States. Front Neurol. 2024;15:1339167.Rodrigues E, Umeh E, Aishwarya, Navaratnarajah
More news about: Amgen
Dec 11, 2025, 14:54 ET Johnson Fistel Investigates the Grindr Board for Potential Breaches of Fiduciary Duties Relating to the Grindr Buyout Termination
this promotional communication, and Frank J. Johnson is the attorney responsible for its content.ContactJohnson Fistel, PLLP501 W. Broadway, Suite 800San Diego, CA 92101James Baker, Investor Relations – or – Frank J. Johnson, Esq.(619) 814-4471 |
More news about: Johnson Fistel, PLLP
Dec 11, 2025, 13:41 ET Deloitte at CES 2026: Igniting the Next Wave of Innovation
Ammanath, Executive Director, Deloitte Global AI Institute, Deloitte LLPMonday, Jan. 5, 2 to 2:40 p.m. | Location: LVCC, West Level 2, W219
More news about: Deloitte
Dec 11, 2025, 10:05 ET Luxor Workspaces Unveils New Lightweight, High-Capacity LuxPower Charging Tower
Specifications:Dimensions: 13" W x 13" D x 26.5" H (Platform: 11" W x 11" D)Weight: 19.8 lbs.Cord Length: 12'Power Capacity: 8 AC outlets (125V), 4 USB-A (12W each), 4 USB-C (45W each)Certifications: UL and cUL 962A
More news about: Luxor Workspaces
Dec 11, 2025, 10:01 ET Hybrid Bonding Market worth $633.9 million by 2032 - Exclusive Report by MarketsandMarkets™
Continuous advancements in plasma activation, alignment optics, and wafer handling further strengthen their dominance. The strong installed base of W2W production lines reinforces their position as the primary bonding technology.Heterogeneous integration segment is expected to record the highest
More news about: MarketsandMarkets
Dec 11, 2025, 10:00 ET Kessler Topaz Meltzer & Check, LLP Announces Proposed Settlement of the SEB Investment Management AB v. Wells Fargo & Company Securities Action
v. WELLS FARGO & COMPANY, CHARLES W. SCHARF, KLEBER R. SANTOS, and CARLY SANCHEZ, Defendants.
More news about: Kessler Topaz Meltzer & Check, LLP
Dec 11, 2025, 10:00 ET Newsweek Names Integrity Best Workplace for Diversity
holistic needs of consumers from all walks of life, we are equally committed to inclusion and social responsibility within our workforce," said Bryan W. Adams, Co-Founder and CEO of Integrity. "This award is a testament to the power of teamwork, community and shared values. Our team is strongest when
More news about: Integrity Marketing Group, LLC
Dec 11, 2025, 09:21 ET W1 REGEN DE MATELASER : lancement sur Kickstarter de l'appareil portatif de luminothérapie rouge le plus léger (24 g) et le plus puissant (5 100 mW/cm²)
de sa campagne mondiale de financement participatif relative au W1 REGEN, un appareil révolutionnaire qui miniaturise la thérapie par laser de qualité clinique au format portable ultracompact de 24 g. Proposé à seulement 99 dollars, le W1 REGEN brise officiellement la barrière du coût d'une véritable
More news about: MateLaser
Dec 11, 2025, 09:14 ET Meishilong Electronics Clinches 2025 Global Electronic Component Distributor "Annual Growth Star Award" - Dual Consecutive Wins Reinforce Industry Leadership
videos released on our YouTube channel:https://www.youtube.com/watch?v=w5F-pHp2rg0https://www.youtube.com/watch?v=SB18GXbxFYc
More news about: Shenzhen Meishilong Electronic Technology Co., Ltd.
Dec 11, 2025, 09:05 ET Institute for Maternal Fetal Health at Nemours Children's Launches to Treat Babies Well Before Birth
Will Begin Treating Patients in Early 2026Preeminent maternal-fetal medicine specialist serves as the inaugural Elizabeth W. Snyder Endowed Chair in Fetal Therapy and InnovationWILMINGTON, Del., Dec.
More news about: Nemours Children's Health
Dec 11, 2025, 09:00 ET Ando Appoints Industry Leaders to Advisory Group to Strengthen Mission to Transform Hourly Work
tools, Ando helps businesses reduce turnover, eliminate labor waste, and give workers schedules they can depend on. Ando is purpose-built for the hourly W2 workforce, supporting employees and the managers who schedule them.Media Contact:
More news about: Ando
Dec 11, 2025, 09:00 ET Top Destinations to Visit in 2026
W Costa Rica – Reserva Conchal, a resort that elevates the travel experience with contemporary design, exceptional dining, and immersive activities
More news about: Marriott International
Dec 11, 2025, 08:30 ET Research Solutions Announces CFO Transition
like to thank Bill for his contributions to the Company over the past four years and welcome Dave into this role as interim CFO and Secretary," said Roy W. Olivier, Chairman and Chief Executive Officer of Research Solutions. "Dave shares the Company's long-term strategic financial vision and has been working
More news about: Research Solutions, Inc.
Dec 11, 2025, 08:05 ET Veteran Commonwealth Advisors Chris Sauve and Dominic Benetti Move Their Great Lakes Wealth Advisors Firm to Cetera
Securities and Exchange Commission include Cetera Investment Management LLC and Cetera Investment Advisers LLC. Cetera's principal office is located at 655 W. Broadway, 11th Floor, San Diego, CA 92101.Cetera exclusively provides investment products and services through its representatives. Although Cetera
More news about: Cetera Financial Group
Dec 11, 2025, 08:00 ET Davis & Shirtliff Named Twice in Business Worldwide Magazine's 2025 Global Corporate Excellence Awards
Jones Awards DepartmentE: [email protected]W: www.bwmonline.com
More news about: Business Worldwide Magazine
Dec 11, 2025, 07:49 ET From Farm to Future: Chefs, Food Industry Leaders, and Engineers Needed to Judge Record-Breaking STEM Competition
Connectivity, UL Research Institutes, and United Engineering Foundation. At the Champion Level: RTX and Shell Energy. At the Supporter Level: BAE Systems, Glenn W. Bailey Foundation, and ON Semiconductor Foundation.About DiscoverE: DiscoverE is a nonprofit organization committed to inspiring and empowering
More news about: Discover Engineering
Dec 11, 2025, 07:30 ET MATELASER W1 REGEN: The Lightest 24g and Highest 5,100 mW/cm² Wearable Red Light Therapy Device Debuts on Kickstarter
therapy, today announced the official launch of its global crowdfunding campaign for the W1 REGEN, a breakthrough device that brings clinic-grade laser therapy into an ultra-miniature 24g wearable form. Priced at just $99, W1 REGEN officially breaks the cost barrier for true medical-grade photobiomodulation,
More news about: MateLaser
Dec 11, 2025, 07:00 ET ezAccounting Now Available for Year-End Tax Reporting
expenses and profits Processes countless payroll checks and stubs for employeesPrints unlimited tax forms 943, 941, 940, W2 and W3 (Copy A preprinted W2 and W3 forms required)Generates a variety of reports for sales, orders, payroll and other business reports.Supports multiple
More news about: Halfpricesoft.com
Dec 11, 2025, 07:00 ET Biohaven Presents Clinical Safety and Efficacy Data for BHV-1510, a Next-Generation Trop2 Antibody Drug Conjugate in Combination with Cemiplimab at the 2025 European Society for Medical Oncology (ESMO) Immuno-Oncology Congress
(Grade 3) at the 2.75 mg/kg Q3W dose. As of the clinical cutoff date, a total of 31 participants were treated with the combination of BHV-1510 and cemiplimab, with BHV-1510 doses ranging from 2-2.75 mg/kg Q3W and 1.25-1.5 mg/kg D1D8Q3W. Cemiplimab was given at 350 mg Q3W.Across all doses BHV-1510,
More news about: Biohaven Ltd.
Dec 11, 2025, 05:00 ET Weyerhaeuser and Aymium Enter Agreement to Rapidly Scale Biocarbon Market
fiber."This partnership combines our renewable fiber resources and supply chain expertise with Aymium's innovative technology and experience," says Devin W. Stockfish, president and chief executive officer of Weyerhaeuser. "It represents a major step forward in growing the scale and impact of our Climate
More news about: Weyerhaeuser Company
Dec 11, 2025, 05:00 ET Weyerhaeuser Outlines Strategy to Accelerate Growth and Drive Significant Value Creation at Investor Day
timberlands, wood products and land solutions space as the only large cap, integrated investment opportunity poised for accelerated growth," says Devin W. Stockfish, president and chief executive officer. "Today's event will showcase the company's unrivaled strengths, competitive advantages and strong track
More news about: Weyerhaeuser Company
Dec 11, 2025, 04:00 ET Firma Nordic Semiconductor wprowadza na rynek oprogramowanie nRF9151 i zestaw rozwojowy do łączności satelitarnej i z komórkowym Internetem rzeczy (IoT)
oferują elastyczne i precyzyjne parametry działania w zakresie częstotliwości radiowych (RF)", mówi Kristian Sćther, starszy dyrektor ds. produktów dalekiego zasięgu w Nordic Semiconductor. „Zestaw rozwojowy nRF9151 zapewnia dokładnie to, co daje ekspertom w dziedzinie częstotliwości radiowych (RF) szczegółową
More news about: Nordic Semiconductor
Dec 11, 2025, 03:00 ET Von flauschigen Kuscheldecken bis Stiftung Warentest-zertifizierten Heizdecken: Bedsure supportet Last Minute-Shopper mit Weihnachtsangeboten
Überwurf. Sie ist GS-, CE- und ROHS-zertifiziert und hat 74 fühlt Sicherheitstests durchlaufen. Dabei verbraucht sie nur 1/20 eines regulären 2000-W-Heizgeräts.UVP*: 54,99 Euro. Im Aktionszeitraum bis zu 27% Rabatt. Rabattstaffelungen variieren nach Größen und Farbe.Kuschelig warm und
More news about: Bedsure
Dec 11, 2025, 00:50 ET 新橋生物公佈 Ragistomig 1期劑量拓展研究數據：療效可比，安全性顯著提升
1期單藥治療 Q6W 數據*數據截止日期：2025年10月22日與 Q2W 方案相比，Ragistomig 在 Q6W 給藥方案中表現出可比的抗腫瘤療效。其中，Q6W 的疾病控制率（DCR）為 58.8%，Q2W則為 64.3%。Ragistomig 在Q6W 組中展現出了顯著提升的良好安全性，20位患者中僅1人的肝功能檢測值升高3級及以上，無人因治療中出現不良事件（TEAEs）而停藥，且未報告細胞因子釋放綜合征。Q6W 和 Q2W 給藥組之間的總體免疫細胞活性一致。Q6W給藥組的免疫細胞藥效動力學數據表明，效應記憶
More news about: 新橋生物